Search clinical trials for: DTRI-031

Total 3001 results

Basking Biosciences, Inc.

Completed

Study of DTRI-031 in Healthy Volunteers

Healthy Volunteers | Pharmacokinetics | Pharmacodynamics

Australia
Basking Biosciences, Inc.

Not yet recruiting

Study of BB-031 in Acute Ischemic Stroke Patients (RAISE) (RAISE)

Acute Ischemic Stroke
Acceleron Pharma Inc. (a wholly owned subsidiary...

Terminated

Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

Canada
Kukje Pharma

Completed

[KSR-001-P01]Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristic of KSR-001

Dry Eye Syndromes

Korea, Republic of
National Cancer Institute (NCI)

Completed

Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection

Head and Neck Cancer | Head and Neck Neoplasms

United States
Patagonia Pharmaceuticals, LLC

Completed

A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis

Congenital Ichthyosis

United States
Cerecin

Completed

Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production

Alzheimer Disease

Australia
Sorrento Therapeutics, Inc.

Withdrawn

A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies

Diffuse Large B Cell Lymphoma | Biliary Tract Cancer | Peripheral T Cell Lymphoma | Extranodal NK T Cell Lymphoma, Nasal
National Cancer Institute (NCI)

Completed

Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines

Prostatic Neoplasms | Prostatic Cancer

United States
EGEN, Inc.

Terminated

A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients

Colorectal Cancer

United States
Children's Hospital of Philadelphia
Friedreich's Ataxia Research Alliance; Stealth BioTherapeutics Inc.

Active, not recruiting

FRDA Investigator Initiated Study (IIS) With Elamipretide (ELViS-FA)

Friedreich Ataxia

United States
Kukje Pharma
Samil Pharmaceutical Co., Ltd.

Completed

[KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome

Dry Eye Syndromes

Korea, Republic of
National Cancer Institute (NCI)

Completed

Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer

Neoplasms | Breast Cancer | Lung Cancer | Prostate Cancer | Colon Cancer

United States
Antengene Biologics Limited

Recruiting

A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

Advanced Solid Tumors | B-cell Non-Hodgkin Lymphomas

United States
Hangzhou Jiayin Biotech Ltd

Recruiting

A Study of EXG102-031 in Participants With wAMD

Neovascular Age-related Macular Degeneration

China
Eleven Biotherapeutics

Withdrawn

Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular Edema

Diabetic Macular Edema
Exegenesis Bio

Recruiting

A Study of EXG102-031 in Patients With wAMD (Everest)

Neovascular (Wet) Age-related Macular Degeneration (nAMD)

United States
Acceleron Pharma Inc. (a wholly owned subsidiary...

Completed

A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 (ActRIIB-IgG1)in Healthy Postmenopausal Volunteers

Muscle Loss

Canada
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study

Melanoma | Metastatic Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Recurrent Metastatic Melanoma

United States
Cerecin

Withdrawn

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Alzheimer's Disease
Zelos Therapeutics

Withdrawn

A Proof-of-Concept Study Investigating the Safety and Efficacy of ZT-031 on Hip Fracture Healing in Men and Postmenopausal Women (SHIFT)

Hip Fracture

United States
Zhejiang DTRM Biopharma

Completed

Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas

Chronic Lymphocytic Leukemia | B-Cell Lymphoma

United States
Cerecin

Completed

Tricaprilin Phase 2 Pilot Study in Migraine

Migraine

Australia
Acceleron Pharma Inc. (a wholly owned subsidiary...

Terminated

Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

Canada
Peking University Third Hospital

Enrolling by invitation

Diffusion MRI in Cervical Spondylotic Myelopathy

Cervical Spondylotic Myelopathy

China
Inova Health Care Services
Boston Scientific Corporation

Completed

Distal Transradial Access for Percutaneous Coronary Intervention

Coronary Angiography | Transradial Access | Radial Artery Intimal Medial Thickness | Distal Radial Artery Access (dTRA)

United States
Medtronic Spinal and Biologics

Completed

Diffusion MRI-1 Imaging Database (dMRI-1)

Epilepsy | Healthy | Tumor | Other

United States, Canada
Federal University of São Paulo
Instituto Paulista de Estudos e Pesquisa em Oftalmologia; Eye Clinic Day Hospital...

Completed

Clinical Outcomes After Bilateral Implantation of ZEISS AT LISA TRI AND TRI TORIC IOL

Cataract

Brazil
Claris Biotherapeutics, Inc.

Recruiting

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars

Corneal Scar

United States
Jens Bräunlich

Recruiting

Ultrasonographic Evaluation of the Diaphragm During NHF Versus NIV Use in Respiratory Failure (SENNI)

Diaphragm Issues | Respiratory Failure With Hypoxia | Respiratory Failure With Hypercapnia | Non-invasive Mechanical Ventilation

Germany
Instituto de Neurologia y Neurocirugia Hospital...

Completed

Accuracy of Markerless Motion Capture Evaluation in Parkinson's Disease After DBS

Parkinson Disease

Mexico
Acceleron Pharma Inc. (a wholly owned subsidiary...

Completed

A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 in Healthy Postmenopausal Women

Muscular Atrophy

Canada
Ohana BioSciences

Unknown

Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation (SPRING)

Infertility | Infertility, Male

United States
Charite University, Berlin, Germany

Completed

Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy (EPOHeart)

Ischemic Cardiomyopathy

Germany
Assistance Publique Hopitaux De Marseille

Unknown

Comparison of Both Metabolic and Functional Effects Induced by Two Neuromuscular Electrical Stimulation Protocols: A Comprehensive Approach Using Magnetic Resonance Imaging and Spectroscopy

Healthy

France
Claris Biotherapeutics, Inc.

Recruiting

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

Neurotrophic Keratitis

United States, Canada
Wang Jianhui

Recruiting

dTDI During a SBT to Predict Extubation Failure in Preterm Infants

Premature

China
Instituto Mexicano del Seguro Social

Enrolling by invitation

Safety and Efficacy Between the Distal and Proximal Radial Vascular Access Technique

Coronary Artery Disease

Mexico
Provention Bio, a Sanofi Company

Completed

At-Risk for Type 1 Diabetes Extension Study (TN-10 Extension)

Diabetes Mellitus, Type 1

United States
University Hospital, Basel, Switzerland
Heidelberg University

Completed

Brain Function and White Matter Changes in Congenital, Acute and Chronic Spinal Cord Lesions

Myelomeningocele | Paraplegia, Spinal

Switzerland
Pusan National University Hospital
Erbe USA Incorporated

Recruiting

Tri-modality Sampling Using Radial Probe Endobronchial Ultrasound for the Diagnosis of Peripheral Pulmonary Lesions

Lung Nodule

Korea, Republic of
Regional Hospital Holstebro

Completed

Five-year Migration Pattern and Bone Mineral Density for the Tri-Lock and Summit Femoral Stems.

THA
M.D. Anderson Cancer Center
Direct Therapeutics

Completed

Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas

Glioma | Brain Neoplasms

United States
University Hospital Muenster

Unknown

DTI in Children With Multiple Sclerosis

Clinically Isolated Syndrome, CNS Demyelinating | Multiple Sclerosis - Relapsing Remitting

Germany
Dr. Reddy's Laboratories Limited

Completed

A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris

Acne Vulgaris

United States
Pronova BioPharma

Completed

Bioavailability of Omega-3 Food Supplement in Healthy Subjects

Biological Availability

United Kingdom
Institut de Recherche pour le Developpement
Medical Research Council; Institut Pasteur; Centre Muraz; REVS PLUS Burkina Faso; Young Gambian Mums Fund and other collaborators

Not yet recruiting

The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM) (TRI-MOM)

Hiv | HBV | Syphilis
Lille Catholic University

Recruiting

Diffusion Tensor (DTI) for the Assessement of Therapeutic Evolution of Patients With Acute Lumbar Radiculalgia (DiTi-Aïe)

Magnetic Resonance Imaging | Lumbar Radiculopathy | Diffusion Tensor Imaging

France
Institute for Biomechanics, ETH Zürich

Completed

The Influence of Stability Boots on Gait Pattern in Healthy Adults

Rehabilitation After Ankle Injuries

Switzerland
University Health Network, Toronto

Completed

Tri-modal Imaging Instrument for Thyroid Cancer

Thyroid Neoplasms | Thyroid Cancer | Thyroid Nodule

Canada

Search clinical trials for: DTRI-031

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations